G. Gaspar

1.6k total citations
29 papers, 336 citations indexed

About

G. Gaspar is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Gaspar has authored 29 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Gaspar's work include HIV/AIDS drug development and treatment (6 papers), Healthcare Systems and Technology (5 papers) and HIV/AIDS Research and Interventions (4 papers). G. Gaspar is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Healthcare Systems and Technology (5 papers) and HIV/AIDS Research and Interventions (4 papers). G. Gaspar collaborates with scholars based in Spain and Colombia. G. Gaspar's co-authors include Javier de Miguel-Dı́ez, Pilar Ramos, José Luís Izquierdo Alonso, Jesús Molina, Carlos Barrós, José Miguel Rodríguez González-Moro, José Sanz, María Velasco, Miguel Cervero and Rafael Torres and has published in prestigious journals such as Hepatology, Advances in experimental medicine and biology and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

G. Gaspar

28 papers receiving 325 citations

Peers

G. Gaspar

ID

EPIDE

PRM

PHYSI

SURGE

Anna Zampini United States

Ann M. Buchanan United States

Gregory Malat United States

Pascal Puglièse France

Ann‐Britt Bohlin Sweden

Willard Tinago Ireland

Paul Collini United Kingdom

Kokuvi Atsou France

J. Evison Switzerland

William R. Cole United States

Anna Zampini United States

G. Gaspar

109 ×0.7

ID

68 ×0.5

EPIDE

145 ×1.3

PRM

30 ×0.6

PHYSI

142 ×3.1

SURGE

Citations per year, relative to G. Gaspar G. Gaspar (= 1×) peers Anna Zampini

Countries citing papers authored by G. Gaspar

Since Specialization

Citations

This map shows the geographic impact of G. Gaspar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gaspar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gaspar more than expected).

Fields of papers citing papers by G. Gaspar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Gaspar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gaspar. The network helps show where G. Gaspar may publish in the future.

Co-authorship network of co-authors of G. Gaspar

This figure shows the co-authorship network connecting the top 25 collaborators of G. Gaspar. A scholar is included among the top collaborators of G. Gaspar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Gaspar. G. Gaspar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Berenguer, Juan, Teresa Aldámiz‐Echevarría, Víctor Hontañón, et al.. (2024). Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis. Hepatology. 81(1). 238–253. 3 indexed citations

2.

Pérez‐Latorre, Leire, Juan Berenguer, Rafael Micán, et al.. (2021). HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018. Eurosurveillance. 26(25). 6 indexed citations

3.

Gaspar, G., et al.. (2015). Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. International Journal of Clinical Pharmacy. 37(5). 865–872. 30 indexed citations

4.

Santos, Ignacio de los, Marisa Montes, José Sanz, et al.. (2014). Efficacy and tolerability of telaprevir (TVR)‐based triple therapy in HIV/HCV‐coinfected patients. Journal of the International AIDS Society. 17(4S3). 19633–19633. 1 indexed citations

5.

Puig, Juan, G. Gaspar, & Juan José Ríos Blanco. (2014). Informe de los Editores, 2014. Revista Clínica Española. 215(1). 50–54. 1 indexed citations

6.

Puig, Juan, G. Gaspar, & Juan José Ríos Blanco. (2013). Informe de los editores, 2013. Revista Clínica Española. 214(1). 38–45.

7.

García‐Puig, Juan, G. Gaspar, & Juan José Ríos Blanco. (2012). Informe de los editores, 2012. Revista Clínica Española. 213(1). 34–41. 4 indexed citations

8.

Puig, Juan, G. Gaspar, & Juan José Ríos Blanco. (2011). Informe de los editores, 2011. Revista Clínica Española. 212(1). 31–39. 4 indexed citations

9.

Puig, Juan, G. Gaspar, & Juan José Ríos Blanco. (2011). Informe de los Editores, 2010. Revista Clínica Española. 211(1). 36–45. 2 indexed citations

10.

Puig, Juan, G. Gaspar, & Juan José Ríos Blanco. (2010). Informe de los editores: 2009. Revista Clínica Española. 210(1). 33–40. 5 indexed citations

11.

Velasco, María, José Sanz, G. Gaspar, et al.. (2009). Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(2). 148–152. 90 indexed citations

12.

Velasco, María, Miguel Cervero, José Sanz, et al.. (2008). The changing pattern of tuberculosis and HIV co‐infection in immigrants and Spaniards in the last 20 years. HIV Medicine. 9(4). 227–233. 11 indexed citations

13.

Velasco, María, Juan Emilio Losa, José Sanz, et al.. (2007). Economic evaluation of assistance to HIV patients in a Spanish hospital. European Journal of Internal Medicine. 18(5). 400–404. 9 indexed citations

14.

Alberdi, J., et al.. (2003). Cohorte multicéntrica de pacientes con infección VIH de la corona metropolitana sudeste de Madrid (COMESEM): fundamentos, organización y resultados iniciales. Revista Clínica Española. 203(4). 170–177. 8 indexed citations

15.

Miguel-Dı́ez, Javier de, José Luís Izquierdo Alonso, Jesús Molina, et al.. (2003). Fiabilidad del diagnóstico de la EPOC en atención primaria y neumología en España. Factores predictivos. Archivos de Bronconeumología. 39(5). 203–208. 64 indexed citations

16.

Miguel-Dı́ez, Javier de, José Luís Izquierdo Alonso, Jesús Molina, et al.. (2003). Fiabilidad del diagnóstico de la EPOC en atención primaria y neumología en España. Factores predictivos. Archivos de Bronconeumología. 39(5). 203–208. 28 indexed citations

17.

Gaspar, G., et al.. (1989). [Primary cutaneous nocardiosis and human immunodeficiency virus infection].. PubMed. 92(15). 598–9. 2 indexed citations

18.

Gaspar, G., et al.. (1985). [Boutonneuse fever and pneumonitis].. Dialnet (Universidad de la Rioja). 85(7). 300–300. 1 indexed citations

19.

Puig, Juan, et al.. (1984). Hypouricemia and Medullary Carcinoma of the Thyroid. Advances in experimental medicine and biology. 165 Pt A. 211–213. 2 indexed citations

20.

Puig, Juan, et al.. (1983). Renal Handling of Uric Acid in Normal Subjects by Means of the Pyrazinamide and Probenecid Tests. The Nephron journals/Nephron journals. 35(3). 183–186. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact